{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:42:26Z","timestamp":1790991746472,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"State of Minnesota\u2019s David J. Tomassoni ALS Research Grant Program","award":["238183"],"award-info":[{"award-number":["238183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00415-024-12425-x","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T03:38:20Z","timestamp":1716349100000},"page":"4620-4627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia"],"prefix":"10.1007","volume":"271","author":[{"given":"Haidara","family":"Kherbek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Y.","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Hinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Staff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-9045","authenticated-orcid":false,"given":"Divyanshu","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"12425_CR1","doi-asserted-by":"crossref","unstructured":"Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP et al (1999) Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 53(5):1071\u20131076","DOI":"10.1212\/WNL.53.5.1071"},{"issue":"3","key":"12425_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G et al (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67(3):330\u2013335","journal-title":"Arch Neurol"},{"key":"12425_CR3","doi-asserted-by":"publisher","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine JG, Desestret V, Dubey D et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 8(4):e1014. https:\/\/doi.org\/10.1212\/NXI.0000000000001014. PMID: 34006622; PMCID: PMC8237398","DOI":"10.1212\/NXI.0000000000001014"},{"issue":"16","key":"12425_CR4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349(16):1543\u20131554","journal-title":"N Engl J Med"},{"issue":"7","key":"12425_CR5","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00415-018-8881-0","volume":"265","author":"N M\u00e9l\u00e9","year":"2018","unstructured":"M\u00e9l\u00e9 N, Berzero G, Maisonobe T, Salachas F, Nicolas G, Weiss N et al (2018) Motor neuron disease of paraneoplastic origin: a rare but treatable condition. J Neurol 265(7):1590\u20131599","journal-title":"J Neurol"},{"issue":"2","key":"12425_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00415-015-7993-z","volume":"263","author":"A H\u00fcbers","year":"2016","unstructured":"H\u00fcbers A, Hildebrandt V, Petri S, Kollewe K, Hermann A, Storch A et al (2016) Clinical features and differential diagnosis of flail arm syndrome. J Neurol 263(2):390\u2013395","journal-title":"J Neurol"},{"issue":"12","key":"12425_CR7","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1002\/acn3.51682","volume":"9","author":"X Han","year":"2022","unstructured":"Han X, Zhan F, Yao Y, Cao L, Liu J, Yao S (2022) Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1-related spectrum. Ann Clin Transl Neurol 9(12):1910\u20131917","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"12425_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ana.26050","volume":"89","author":"D Dubey","year":"2021","unstructured":"Dubey D, Kryzer T, Guo Y, Clarkson B, Cheville JC, Costello BA et al (2021) Leucine zipper 4 autoantibody: a novel germ cell tumor and paraneoplastic biomarker. Ann Neurol 89(5):1001\u20131010","journal-title":"Ann Neurol"},{"issue":"10","key":"12425_CR9","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1373\/clinchem.2015.253740","volume":"62","author":"JR Mills","year":"2016","unstructured":"Mills JR, Kohlhagen MC, Dasari S, Vanderboom PM, Kyle RA, Katzmann JA et al (2016) Comprehensive assessment of M-proteins using nanobody enrichment coupled to MALDI-TOF mass spectrometry. Clin Chem 62(10):1334\u20131344","journal-title":"Clin Chem"},{"key":"12425_CR10","unstructured":"Dubey D M-BC, Kryzer T, O'Donovan B, Tran B, Vazquez S, Sample H, Zorn K, Kahn L, Bledsoe I, McKeon A, Pleasure S, Gandhi M, Lennon V, DeRisi J, Pittock S, Wilson M (2019) Kelch-like protein 11 autoantibodies are a novel biomarker of testicular cancer-associated paraneoplastic encephalitis. Am Acad Neurol"},{"issue":"8","key":"12425_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/jnnp.2006.105056","volume":"78","author":"S Vucic","year":"2007","unstructured":"Vucic S, Kiernan MC (2007) Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 78(8):849\u2013852","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3\u20134","key":"12425_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/21678421.2014.965178","volume":"16","author":"P Corcia","year":"2015","unstructured":"Corcia P, Gordon PH, Camdessanche JP (2015) Is there a paraneoplastic ALS? Amyotroph Lateral Scler Frontotemporal Degener 16(3\u20134):252\u2013257","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"12425_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75(8):1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"12425_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMoa1816721","volume":"381","author":"C Mandel-Brehm","year":"2019","unstructured":"Mandel-Brehm C, Dubey D, Kryzer TJ, O\u2019Donovan BD, Tran B, Vazquez SE et al (2019) Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med 381(1):47\u201354","journal-title":"N Engl J Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12425-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:42:54Z","timestamp":1720521774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12425-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["12425"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12425-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.K., C.I. C.D., S.E., S.H., N.S. report no conflicts interest. S.J.P. reports receiving grants, personal fees paid to Mayo Clinic, and nonfinancial support from Alexion Pharmaceuticals, Inc. and MedImmune, Inc.\/Viela Bio; receiving personal fees from Genentech\/Roche, UCB, and Astellas, outside the submitted work; holding patent 8,889,102 (application 12-678350) issued and patent 9,891,219B2 (application 12-573942) issued. D.D. has consulted for UCB, Immunovant, Argenx, Arialys, and Astellas pharmaceuticals. All compensation for consulting activities is paid directly to Mayo Clinic. He is a named inventor on filed patent that relates to KLHL11 as marker of autoimmunity and germ cell tumor. He has patents pending for LUZP4-IgG, cavin-4-IgG and SKOR2-IgG as markers of neurological autoimmunity. He has received funding from the DOD (CA210208 & PR220430), David J. Tomassoni ALS Research Grant Program and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}